153 related articles for article (PubMed ID: 12168116)
1. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.
Fan X; Muñoz J; Sanko SG; Castresana JS
Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.
Muñoz J; Lázcoz P; Inda MM; Nistal M; Pestaña A; Encío IJ; Castresana JS
Int J Cancer; 2004 May; 109(5):673-9. PubMed ID: 14999773
[TBL] [Abstract][Full Text] [Related]
3. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
[TBL] [Abstract][Full Text] [Related]
4. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
5. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
7. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
8. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ;
Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623
[TBL] [Abstract][Full Text] [Related]
10. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
[TBL] [Abstract][Full Text] [Related]
11. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in pediatric high-grade astrocytomas.
Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS
Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
[TBL] [Abstract][Full Text] [Related]
13. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).
Fuller CE; Wang H; Zhang W; Fuller GN; Perry A
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1078-84. PubMed ID: 12484570
[TBL] [Abstract][Full Text] [Related]
14. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
15. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.
Fuller CE; Schmidt RE; Roth KA; Burger PC; Scheithauer BW; Banerjee R; Trinkaus K; Lytle R; Perry A
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1118-28. PubMed ID: 14656070
[TBL] [Abstract][Full Text] [Related]
17. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
Poetsch M; Lorenz G; Kleist B
Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular analyses of 10q deletions in human gliomas.
Steck PA; Lin H; Langford LA; Jasser SA; Koul D; Yung WK; Pershouse MA
Genes Chromosomes Cancer; 1999 Feb; 24(2):135-43. PubMed ID: 9885980
[TBL] [Abstract][Full Text] [Related]
19. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.
Idoate MA; Soria E; Lozano MD; Sola JJ; Panizo A; de Alava E; Manrique M; Pardo-Mindán FJ
Diagn Mol Pathol; 2003 Sep; 12(3):160-5. PubMed ID: 12960698
[TBL] [Abstract][Full Text] [Related]
20. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
Sung T; Miller DC; Hayes RL; Alonso M; Yee H; Newcomb EW
Brain Pathol; 2000 Apr; 10(2):249-59. PubMed ID: 10764044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]